Evidence map›Paper›PMID 40585850›Full record

ArticleFrontiers in bioengineering and biotechnology2025

Genetically modified microorganisms for agricultural use: an opportunity for the advancement of risk assessment criteria in Argentina.

Clara Rubinstein, Gabriela Levitus, Carmen Vicien, Natalia Andrea Modena, Sandra Ruzal, Facundo Vesprini, Dalia Marcela Lewi, Cecilia Caminoa, Maria Fabiana Malacarne, Nerina Francescutti and 1 more

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. What´s in a name: the issue with regulatory definitions.Frontiers in bioengineering and biotechnology · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Clara RubinsteinInstitute for Scientific Cooperation on Health and the Environment (ICCAS), Buenos Aires, Argentina.
Gabriela LevitusArgentine Association for the Development and Education in Biotechnology (ArgenBio), Buenos Aires, Argentina.
Carmen VicienInstitute for Scientific Cooperation on Health and the Environment (ICCAS), Buenos Aires, Argentina.
Natalia Andrea ModenaBayer Crop Science, Buenos Aires, Argentina.
Sandra RuzalBiochemistry Institute, Exact and Sciences School, University of Buenos Aires, Buenos Aires, Argentina.
Facundo VespriniBayer Crop Science, Buenos Aires, Argentina.
Dalia Marcela LewiInstituto Nacional de Tecnología Agropecuaria, Buenos Aires, Argentina.
Cecilia CaminoaBASF SA, Buenos Aires, Argentina.
Maria Fabiana MalacarneArgentine Seed Association, Buenos Aires, Argentina.
Nerina FrancescuttiBayer Crop Science, Buenos Aires, Argentina.
Juan Ignacio AmaturoCorteva Agriscience SRL, Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development and use of biologicals in agriculture is of growing interest globally. The potential of these tools to increase and protect yield complementing other tools has stimulated the interest of developers. Agricultural countries like Brazil and Argentina in Latin America have extensive experience with the use of biologicals for biocontrol and as seed inoculants. The last decade has seen the number of bio-based startups grow in the region, many of those dedicated to the development of microbial based bio-inputs. The potential for improving the efficacy and functionality of these products by means of gene technologies is very promising; however, the regulatory oversight of these innovations needs adaptation to become fit for purpose. The Biotechnology Working Group at ICCAS identified the need for a science-based discussion on this matter and considered alternatives to the current paradigm, developed over 30 years ago for transgenic plants.

Indexed as

bio-inputsbiologicalsbiosafetymicroorganismsrisk assessment

Identifiers

PMID40585850
PMCPMC12202534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.